Providing information about prenatal screening for Down syndrome: A systematic review

Acta Obstetricia et Gynecologica Scandinavica

Volumn 94, Issue 2, 2015, Pages 125-132

  Skjøth, Mette M ^a   Draborg, Eva ^b   Pedersen, Claus D ^a   Hansen, Helle P ^b   Lamont, Ronald F ^a,c   Jørgensen, Jan S ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Down syndrome; Informed choice; pregnancy; prenatal diagnosis; systematic review

Indexed keywords

ANXIETY; CONFLICT; DEPRESSION; DOWN SYNDROME; HUMAN; MEDICAL INFORMATION; PATIENT SATISFACTION; PATIENT WORRY; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; CHECKLIST; COUNSELING; DECISION MAKING; FEMALE; PATIENT EDUCATION; PREGNANCY; PROCEDURES; TREATMENT OUTCOME;

CHECKLIST; COUNSELING; DECISION MAKING; DOWN SYNDROME; FEMALE; HUMANS; PATIENT EDUCATION AS TOPIC; PREGNANCY; PRENATAL DIAGNOSIS; TREATMENT OUTCOME;

EID: 84921604617     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1111/aogs.12543     Document Type: Review

References (39)

1. Roizen NJ, Patterson D,. Down's syndrome. Lancet. 2003; 361: 1281-9.
2. Tabor A, Alfirevic Z,. Update on procedure-related risks for prenatal diagnosis techniques. Fetal Diagn Ther. 2009; 27: 1-7.
3. Nicolaides KH, Spencer K, Avgidou K, Faiola S, Falcon O,. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Ultrasound Obstet Gynecol. 2005; 25: 221-6.
4. The Danish Health and Medicines Authority. Retningslinjer for Fosterdiagnostik. [Guidelines for prenatal diagnosis]. Copenhagen: Sundhedsstyrelsen, 2004.
5. O'Connor A, O'Brien-Pallas LL,. Decisional conflict. In:, McFarland GK, McFarlane EA, (eds). Nursing diagnosis and intervention. Toronto: The C.V. Mosby Company, 1989. pp. 573-88.
6. Stefansdottir V, Skirton H, Jonasson K, Hardardottir H, Jonsson JJ,. Effects of knowledge, education, and experience on acceptance of first trimester screening for chromosomal anomalies. Acta Obstet Gynecol Scand. 2010; 89: 931-8.
7. Dahl K, Hvidman L, Jørgensen FS, Kesmodel US,. Knowledge of prenatal screening and psychological management of test decisions. Ultrasound Obstet Gynecol. 2011; 38: 152-7.
8. van den Berg M, Timmermans DR, Ten Kate LP, van Vugt JM, van der Wal G,. Are pregnant women making informed choices about prenatal screening? Genet Med. 2005; 7: 332-8.
9. Björklund U, Marsk A, Levin C, Öhman SG,. Audiovisual information affects informed choice and experience of information in antenatal Down syndrome screening-a randomized controlled trial. Patient Educ Couns. 2012; 86: 390-5.
10. Michie S, Dormandy E, Marteau TM,. The multi-dimensional measure of informed choice: a validation study. Patient Educ Couns. 2002; 48: 87-91.
11. Dormandy E, Michie S, Hooper R, Marteau TM,. Informed choice in antenatal Down syndrome screening: a cluster-randomised trial of combined versus separate visit testing. Patient Educ Couns. 2006; 61: 56-64.
12. Bangsgaard L, Tabor A,. Do pregnant women and their partners make an informed choice about first trimester risk assessment for Down syndrome, and are they satisfied with the choice? Prenat Diagn. 2013; 33: 146-52.
13. Thornton JG, Hewison J, Lilford RJ, Vail A,. A randomised trial of three methods of giving information about prenatal testing. BMJ. 1995; 311: 1127-30.
14. Glazier R, Goel V, Holzapfel S, Summers A, Pugh P, Yeung M,. Written patient information about triple-marker screening: a randomized, controlled trial. Obstet Gynecol. 1997; 90: 769-74.
15. Murray J, Cuckle H, Sehmi I, Wilson C, Ellis A,. Quality of written information used in Down syndrome screening. Prenat Diagn. 2001; 21: 138-42.
16. Smith DK, Shaw RW, Marteau TM,. Informed consent to undergo serum screening for Down's syndrome: the gap between policy and practice. BMJ. 1994; 309: 776.
17. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009; 339: b2700.
18. Downs SH, Black N,. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health. 1998; 52: 377-84.
19. Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med. 2010; 152: 726-32.
20. Sundhedsstyrelsen [Board of Health]. SfR Checkliste 2: Randomiserede kontrollerede undersøgelser. [SFR Checklist 2: Randomized controlled trials.] Available online at: http://www.kliniskeretningslinjer.dk/images/checkliste-rct.doc (accessed August 12, 2014).
21. Liddle J,. Method for evaluating research and guideline evidence. New South Wales Public Health Bull. 1997; 8: 5.
22. Marteau TM, Kidd J, Michie S, Cook R, Johnston M, Shaw RW,. Anxiety, knowledge and satisfaction in women receiving false positive results on routine prenatal screening: A randomized controlled trial. J Psychosom Obstet Gynaecol. 1993; 14: 185-96.
23. Graham W, Smith P, Kamal A, Fitzmaurice A, Smith N, Hamilton N,. Randomised controlled trial comparing effectiveness of touch screen system with leaflet for providing women with information on prenatal tests. BMJ. 2000; 320: 155-60.
24. Hewison J, Cuckle H, Baillie C, Sehmi I, Lindow S, Jackson F, et al. Use of videotapes for viewing at home to inform choice in Down syndrome screening: a randomised controlled trial. Prenat Diagn. 2001; 21: 146-9.
25. Cope CD, Lyons AC, Donovan V, Rylance M, Kilby MD,. Providing letters and audiotapes to supplement a prenatal diagnostic consultation: effects on later distress and recall. Prenat Diagn. 2003; 23: 1060-7.
26. Bekker HL, Hewison J, Thornton JG,. Understanding why decision aids work: linking process with outcome. Patient Educ Couns. 2003; 50: 323-9.
27. Leung KY, Lee CP, Chan HY, Tang MH, Lam YH, Lee A,. Randomised trial comparing an interactive multimedia decision aid with a leaflet and a video to give information about prenatal screening for Down syndrome. Prenat Diagn. 2004; 24: 613-8.
28. Nagle C, Gunn J, Bell R, Lewis S, Meiser B, Metcalfe S, et al. Use of a decision aid for prenatal testing of fetal abnormalities to improve women's informed decision making: a cluster randomised controlled trial [ISRCTN22532458]. BJOG. 2008; 115: 339-47.
29. Kuppermann M, Norton ME, Gates E, Gregorich SE, Learman LA, Nakagawa S, et al. Computerized prenatal genetic testing decision-assisting tool: a randomized controlled trial. Obstet Gynecol. 2009; 113: 53-63.
30. Hwa HL, Huang LH, Hsieh FJ, Chow SN,. Informed consent for antenatal serum screening for Down syndrome. Taiwan J Obstet Gynecol. 2010; 49: 50-6.
31. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med. 2001; 134: 663-94.
32. Aczel AD,. Complete business statistics. Boston: Irwin/McGraw Hill, 1999.
33. Jadad AR, Enkin MW,. Randomized controlled trials: questions, answers, and musings, 2nd edn. Malden: Blackwell Publishing, 2007.
34. Schwartz D, Lellouch J,. Explanatory and pragmatic attitudes in therapeutical trials. J Clin Epidemiol. 2009; 62: 499-505.
35. Treweek S, Zwarenstein M,. Making trials matter: pragmatic and explanatory trials and the problem of applicability. Trials. 2009; 10: 37.
36. Dahl K, Kesmodel U, Hvidman L, Olesen F,. Informed consent: providing information about prenatal examinations. Acta Obstet Gynecol Scand. 2006; 85: 1420-5.
37. Vlemmix F, Warendorf JK, Rosman AN, Kok M, Mol BW, Morris JM, et al. Decision aids to improve informed decision-making in pregnancy care: a systematic review. BJOG. 2013; 120: 257-66.
38. O'Connor AM, Bennett CL, Stacey D, Barry M, Col NF, Eden KB, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2009; 3: CD001431.
39. Gigerenzer G, Muir Gray JA, (eds). Better doctors, better patients better decisions. Envisioning Health Care 2020. Strüngmann Forum Reports. Cambridge, MA: The MIT Press, 2011.